<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>374</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15708450</PubmedId>
            <Abstract>The current study describes both Abeta and tau abnormalities that accumulate in the brains of aged (16-21 years), but not young (&lt;4 years) clinically characterized cats. Diffuse plaques that were morphologically different from what is typically observed in the human brain could be detected with 4G8 (Abeta17-24) or an Abeta1-42-specific antibody but not with N-terminal Abeta or an Abeta1-40-specific antibody. SELDI-TOF mass spectrometry experiments indicated that cat brain Abeta consisted almost entirely of Abeta1-42. Markers of tau hyperphosphorylation (AT8 and PHF-1) labeled a subset of neurons in two aged animals. In the hilus of the hippocampus, a subset of AT8 positive neurons showed a sprouting morphology similar to that observed in human brain. Western blot analysis with antibodies against hyperphosphorylated tau indicated that tau is hyperphosphorylated in the aged cat and contains many of the same epitopes found in Alzheimer's disease (AD) brain. Thus, the aged cat brain develops AD-related lesions with important morphological and biochemical differences compared to human brain.</Abstract>
            <ArticleYear>2005</ArticleYear>
            <ArticlePages>749-63</ArticlePages>
            <ArticleTitle>Beta-amyloid deposition and tau phosphorylation in clinically characterized aged cats.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Head</LastName>
                    <ForeName>E</ForeName>
                </Author>
                <Author>
                    <LastName>Moffat</LastName>
                    <ForeName>K</ForeName>
                </Author>
                <Author>
                    <LastName>Das</LastName>
                    <ForeName>P</ForeName>
                </Author>
                <Author>
                    <LastName>Sarsoza</LastName>
                    <ForeName>F</ForeName>
                </Author>
                <Author>
                    <LastName>Poon</LastName>
                    <ForeName>W W</ForeName>
                </Author>
                <Author>
                    <LastName>Landsberg</LastName>
                    <ForeName>G</ForeName>
                </Author>
                <Author>
                    <LastName>Cotman</LastName>
                    <ForeName>Carl W</ForeName>
                </Author>
                <Author>
                    <LastName>Murphy</LastName>
                    <ForeName>M P</ForeName>
                </Author>
            </Authors>
            <Affiliations>Department of Neurology, Institute for Brain Aging and Dementia, University of California, Irvine, CA 92697-4540, USA. ehead@uci.edu</Affiliations>
            <ArticleChemicalList>Amyloid beta-Peptides;tau Proteins</ArticleChemicalList>
            <ArticleMeshHeadingsList>Aging(metabolism); Amyloid beta-Peptides(metabolism); Animals; Behavior, Animal; Blotting, Western(methods); Brain(anatomy &amp; histology; metabolism; pathology); Cats; Dogs; Female; Humans; Immunohistochemistry(methods); Male; Mass Spectrometry(methods); Mice; Mice, Transgenic; Phosphorylation; Protein Array Analysis(methods); Rats; tau Proteins(metabolism)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>26</Volume>
                <Issue>5</Issue>
                <Title>Neurobiology of aging</Title>
                <Issn>0197-4580</Issn>
                <MedlineTa>Neurobiol Aging</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>AB17-24</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LVFFAEDV</LinearSequence>
                        <StartingPosition>688</StartingPosition>
                        <EndingPosition>695</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P05067.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 3</LocationOfData>
                <EpitopeId>40332</EpitopeId>
                <ReferenceStartingPosition>17</ReferenceStartingPosition>
                <ReferenceEndingPosition>24</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 4, Figures 2 and 3</LocationOfData>
                        <BCellId>18622</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>DAEFRHDSGYEVHHQKLVFFAEDV</LinearSequence>
                                            <StartingPosition>672</StartingPosition>
                                            <EndingPosition>695</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P05067.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Generation of the monoclonal antibody was previously described in the reference: Bancher et al. (1989) Neurobiol Aging 10(2):125-32 [PMID: 2657463].</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>38</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Immunohistochemical staining shows positive reactivity in various brain regions: outer molecular layer, parahippocampal cortex, prefrontal cortex, parietal cortex and occipital cortex.The material assayed was an antibody against the epitope, however, whether the antibody is monoclonal or polyclonal is not mentioned in the manuscript.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>4G8</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2b</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Amyloid beta A4 protein precursor (APP)</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P05067.3</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <BCellId>18623</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                                <Sex>F</Sex>
                                <Age>8 weeks</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Fragment of Source Antigen</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>DAEFRHDSGYEVHHQKLVFFAEDV</LinearSequence>
                                            <StartingPosition>672</StartingPosition>
                                            <EndingPosition>695</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P05067.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Generation of the monoclonal antibody was previously described in the reference: Bancher et al. (1989) Neurobiol Aging 10(2):125-32 [PMID: 2657463].</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>248</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The antibody bound to AB1-42 peptide present in the soluble and insoluble fractions of aged cat brain.The material assayed was an antibody against the epitope, however, whether the antibody is monoclonal or polyclonal is not mentioned in the manuscript.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>4G8</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2b</AssayedAntibodyHeavyChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LVFFAEDV</LinearSequence>
                                        <StartingPosition>688</StartingPosition>
                                        <EndingPosition>695</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P05067.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>AB1-17</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>DAEFRHDSGYEVHHQKL</LinearSequence>
                        <StartingPosition>672</StartingPosition>
                        <EndingPosition>688</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P05067.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 3</LocationOfData>
                <EpitopeId>7492</EpitopeId>
                <ReferenceStartingPosition>1</ReferenceStartingPosition>
                <ReferenceEndingPosition>17</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <BCellId>18640</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Unknown</InVivoProcessType>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The source protein is cleaved naturally to give beta amyloid peptides in vivo which are the components of plaques found in Alzheimer's disease brains.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>248</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The antibody bound to AB1-42 peptide present in the soluble and insoluble fractions of aged cat brain.The material assayed was an antibody against the epitope, however, whether the antibody is monoclonal or polyclonal is not mentioned in the manuscript.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Other</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyName>6E10</AssayedAntibodyName>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DAEFRHDSGYEVHHQKL</LinearSequence>
                                        <StartingPosition>672</StartingPosition>
                                        <EndingPosition>688</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P05067.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>AB1-42</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA</LinearSequence>
                        <StartingPosition>672</StartingPosition>
                        <EndingPosition>713</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P05067.3</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Table 3</LocationOfData>
                <EpitopeId>7493</EpitopeId>
                <ReferenceStartingPosition>1</ReferenceStartingPosition>
                <ReferenceEndingPosition>42</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 4, Figures 2 and 4</LocationOfData>
                        <BCellId>18657</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA</LinearSequence>
                                            <StartingPosition>672</StartingPosition>
                                            <EndingPosition>713</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P05067.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The source protein is cleaved naturally to give beta amyloid peptides in vivo which are the components of plaques found in Alzheimer's disease brains.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>38</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>Immunohistochemical staining shows positive reactivity in various brain regions: outer molecular layer, parahippocampal cortex, prefrontal cortex, parietal cortex and occipital cortex.The material assayed was an antibody against the epitope, however, whether the antibody is monoclonal or polyclonal is not mentioned in the manuscript.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Other</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyName>AB1-42</AssayedAntibodyName>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Amyloid beta A4 protein precursor (APP)</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P05067.3</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Not determined</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 5</LocationOfData>
                        <BCellId>18658</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10090</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Epitope</EpitopeRelation>
                                    <Object>
                                        <FragmentOfANaturalSequenceMolecule>
                                            <ChemicalType>Peptide from protein</ChemicalType>
                                            <LinearSequence>DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA</LinearSequence>
                                            <StartingPosition>672</StartingPosition>
                                            <EndingPosition>713</EndingPosition>
                                            <SourceMolecule>
                                                <GenBankId>P05067.3</GenBankId>
                                            </SourceMolecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </FragmentOfANaturalSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>The source protein is cleaved naturally to give beta amyloid peptides in vivo which are the components of plaques found in Alzheimer's disease brains.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>248</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The antibody bound to AB1-42 peptide present in the soluble and insoluble fractions of aged cat brain.The material assayed was an antibody against the epitope, however, whether the antibody is monoclonal or polyclonal is not mentioned in the manuscript.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Other</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyName>AB1-42</AssayedAntibodyName>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>AB1-42</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIA</LinearSequence>
                                        <StartingPosition>672</StartingPosition>
                                        <EndingPosition>713</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P05067.3</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

